Ray Snyder
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cancer survivorship and care
- Cancer Risks and Factors
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 12
- Cancer Treatment and Pharmacology 6
- HER2/EGFR in Cancer Research 6
- Colorectal Cancer Treatments and Studies 1
-
- Breast Cancer Treatment Studies 4
- Co-authors
- Alan S. Coates (5 shared papers)Val Gebski (2 shared papers)VJ Harvey (1 shared paper)Robert L. Woods (1 shared paper)James F. Bishop (1 shared paper)P. N. Jeal (1 shared paper)G Gill (1 shared paper)Martin H.N. Tattersall (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Cancer (1 paper)Journal of Clinical Oncology (1 paper)New England Journal of Medicine (1 paper)The Breast (1 paper)
- Partner nations
- AustraliaUnited StatesSwitzerland
In The Last Decade
Ray Snyder
14 papers receiving 811 citations
Ray Snyder's Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 652
- Cancer Research 251
- Pulmonary and Respiratory Medicine 170
- Otorhinolaryngology 18
- Pediatrics, Perinatology and Child Health 80
Countries citing papers authored by Ray Snyder
This map shows the geographic impact of Ray Snyder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ray Snyder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ray Snyder more than expected).
Fields of papers citing papers by Ray Snyder
This network shows the impact of papers produced by Ray Snyder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ray Snyder. The network helps show where Ray Snyder may publish in the future.
Co-authors
The 25 scholars most cited alongside Ray Snyder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Improving the Quality of Life during Chemotherapy for Advanced Breast Cancer Hit paper breakdown → | 1987 | 419 |
| 2 | 2004 | 202 | |
| 3 | 2009 | 51 | |
| 4 | 2011 | 46 | |
| 5 | 2003 | 33 | |
| 6 | 1979 | 21 | |
| 7 | 2014 | 17 | |
| 8 | 1994 | 15 | |
| 9 | 2004 | 15 | |
| 10 | 2010 | 10 | |
| 11 | 1978 | 8 | |
| 12 | 2018 | 3 | |
| 13 | 2008 | 2 | |
| 14 | Phase I study of epirubicin given on a weekly schedule. | 1987 | 1 |
About Ray Snyder
Ray Snyder is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 843 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (6 papers), Breast Cancer Treatment Studies (4 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Radiopharmaceutical Chemistry and Applications (1 paper), Metabolism, Diabetes, and Cancer (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Medical Imaging Techniques and Applications (1 paper). The work is most often cited by research in Oncology (652 citations), Cancer Research (251 citations), Pulmonary and Respiratory Medicine (170 citations), Otorhinolaryngology (18 citations) and Pediatrics, Perinatology and Child Health (80 citations). Ray Snyder has collaborated with scholars based in Australia, United States and Switzerland. Frequent co-authors include Alan S. Coates, Val Gebski, VJ Harvey, Robert L. Woods, James F. Bishop, P. N. Jeal, G Gill, Martin H.N. Tattersall, Maureen Byrne and Richard D. Gelber. Their work appears in journals such as Annals of Oncology, Cancer, Journal of Clinical Oncology, New England Journal of Medicine and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.